Evidence map›Paper›PMID 38765925›Full record

ArticlePsychiatry and clinical psychopharmacology2023

Life Chart of Substance Use Career: A Clinical Profile Study from Turkey.

Cavid Guliyev, Melike Simsek, Sevinc Bezek-Dino, Kultegin Ogel

Abstract read
In one paragraph

Article in Psychiatry and clinical psychopharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Why Do Adolescents Relapse? A Multicenter, Cross-sectional Study.Psychiatry and clinical psychopharmacology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cavid GuliyevDepartment of Psychology, Istanbul Kent University, Istanbul, Turkey.ORCID 0000-0002-1398-8164
Melike SimsekThe Turkish Green Crescent Counseling Center, Istanbul, Turkey.ORCID 0000-0001-8960-4238
Sevinc Bezek-DinoAlcohol and Substance Addiction Treatment Center, Moodist Psychiatry Hospital, Istanbul Turkey.ORCID 0000-0002-2680-8302
Kultegin OgelDepartment of Psychology, Istanbul Kent University, Istanbul, Turkey.ORCID 0000-0002-6945-0961

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The "career approach," developed to understand substance use and treatment, is important because it can broadly encompass the complexity of addiction patterns and help to better illustrate the chronic and recurrent nature, correlations, and consequences of addiction. The current study aimed to examine the substance use career and patterns of patients diagnosed with substance use disorder. Methods: The authors created a questionnaire that included questions inquiring at what age several substance use-related life events occurred. The Addiction Profile Index was used to collect sociodemographic data and measure substance use disorder severity. Descriptive statistics and group comparisons were conducted to evaluate the data. Results: Of the cases (n = 400), 72.7% began using substances before the age of 18, but only 12.4% (n = 68) sought treatment by that age. There were approximately 8 years between starting substance use and seeking treatment. Substance use was noticed by the family approximately 5 years after it started. There was a difference between males and females in terms of the age of experiencing adverse life events due to substance use, with females being earlier ( Conclusion: Identifying patient characteristics associated with the course of use in people who use different substances of choice and examining the differences in lifelong substance use patterns among these groups will help develop targeted treatment services and policies.

Identifiers

PMID38765925
PMCPMC11082583

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.